首页> 美国卫生研究院文献>AIDS Research and Therapy >Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

【2h】

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

机译：在基于NNRTI的抗逆转录病毒疗法中从司他夫定/拉米夫定改为替诺福韦/拉米夫定后的肾功能损害

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundDuring stavudine phase-out plan in developing countries, tenofovir is used to substitute stavudine. However, knowledge regarding whether there is any difference of the frequency of renal injury between tenofovir/lamivudine/efavirenz and tenofovir/lamivudineevirapine is lacking.

机译：背景在发展中国家淘汰司他夫定的计划中，使用替诺福韦替代司他夫定。但是，缺乏关于替诺福韦/拉米夫定/依非韦伦和替诺福韦/拉米夫定/奈韦拉平之间肾损伤频率是否存在差异的知识。

著录项

期刊名称 AIDS Research and Therapy
作者
Weerawat Manosuthi; Wiroj Mankatitham; Aroon Lueangniyomkul; Wisit Prasithsirikul; Preecha Tantanathip; Busakorn Suntisuklappon; Anongnuch Narkksoksung; Samruay Nilkamhang; Somnuek Sungkanuparph;
展开▼
作者单位

展开▼
年(卷),期 2010(7),-1
年度 2010
页码 37
总页数 8
原文格式 PDF
正文语种
中图分类病毒传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens [J] . Weerawat Manosuthi, Wiroj Mankatitham, Aroon Lueangniyomkul, AIDS Research and Therapy . 2010,第1期

机译：在基于NNRTI的抗逆转录病毒疗法中从司他夫定/拉米夫定改为替诺福韦/拉米夫定后的肾功能损害
2. Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: a prospective study. [J] . Manosuthi W, Lueangniyomkul A, Mankatitham W, Journal of Infection . 2011,第5期

机译：在基于NNRTI的抗逆转录病毒方案中长期使用司他夫定/拉米夫定后改用替诺福韦/拉米夫定的代谢益处：一项前瞻性研究。
3. Change in serum lipid profiles and glucose after switching from stavudine/lamivudine to zidovudine/lamivudine in non-nucleoside reverse transcriptase inhibitors based anti-retroviral regimens in Southern Ethiopia [J] . Agete Tadewos, Demissie Assegu Journal of AIDS and HIV Research . 2015,第2期

机译：在基于埃塞俄比亚南部非核苷类逆转录酶抑制剂的抗逆转录病毒方案中，从司他夫定/拉米夫定改为齐多夫定/拉米夫定后，血清脂质谱和葡萄糖的变化
4. Assay Development Challenges for Determination of Abacavir, Darunavir, Etravirine, Lamivudine, Nevirapine, Saquinavir, Stavudine, and Zidovudine in Human Plasma by LC/MS/MS [C] . Spencer Carter, Brad Bessette, Benjamin Smith, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：LC / MS / MS测定Abacavir，Darunavir，etravirine，Lamivudine，Nevirapine，Saquinavir，Stavudine和Zidovudine的测定挑战
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen [O] . R. Campo, E. DeJesus, U. F. Bredeek, -1

机译：SWIFT：前瞻性48周研究评估了在病毒学抑制的HIV-1感染患者中使用抗逆转录病毒疗法增强的蛋白酶抑制剂后从拉米夫定/依巴韦星转用恩曲他滨/替诺福韦的疗效和安全性
7. Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens [O] . Weerawat Manosuthi, Wiroj Mankatitham, Aroon Lueangniyomkul, 2012

机译：在基于NNRTI的抗逆转录病毒疗法中从司他夫定/拉米夫定改为替诺福韦/拉米夫定后的肾功能损害

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

摘要

著录项

相似文献

相关主题

期刊订阅